Evidence map›Paper›PMID 42797696›Full record

ArticleToxics2026

Accelerating Cosmetic Innovation Through Next-Generation Computational Toxicology: From Structural Alerts to Molecular Dynamics and Artificial Intelligence for Skin Sensitization Assessment.

Thomas Enrique Quintero-Trujillo, Liseth Diaz-Rojas, Helen Andrade, Paola Alfonso-Romero

Abstract read
In one paragraph

Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas Enrique Quintero-TrujilloResearch, Development & Innovation, Belcorp, Tocancipa 251017, Colombia.
Liseth Diaz-RojasResearch, Development & Innovation, Belcorp, Tocancipa 251017, Colombia.
Helen AndradeResearch, Development & Innovation, Belcorp, Tocancipa 251017, Colombia.
Paola Alfonso-RomeroResearch, Development & Innovation, Belcorp, Tocancipa 251017, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin sensitization remains a critical toxicological endpoint in cosmetic ingredient development, particularly under accelerated innovation cycles and increasingly stringent safety requirements. Although NAMs have achieved substantial regulatory maturity for this endpoint, most computational approaches-including structural alerts, read-across, and quantitative structure-activity relationship models-rely predominantly on chemical structure and statistical associations, with limited representation of the molecular processes underlying sensitization. This perspective proposes a transparent and testable computational framework that integrates conventional chemical descriptors, reaction-domain information, covalent docking, molecular dynamics simulations, and machine learning methods. The framework is organized around the skin sensitization adverse outcome pathway and focuses on generating mechanistically informed descriptors associated with the molecular initiating event and selected molecular processes related to keratinocyte activation. These descriptors include reactive geometry, residue accessibility, interaction persistence, conformational behavior, and perturbation hypotheses involving the KEAP1-NRF2 regulatory axis. Rather than replacing established experimental NAMs or DAs, the proposed workflow is intended as a complementary, tiered evidence layer for the early prioritization of structurally characterized cosmetic ingredients and for guiding subsequent experimental testing. Its future value will depend on module-level validation, demonstration of incremental predictive performance, explicit applicability-domain and uncertainty assessment, computational scalability, and prospective comparison with established NAM outcomes.

Indexed as

artificial intelligencecomputational toxicologydeep learningmolecular dynamicsNew Approach Methodologies (NAMs)skin sensitization

Identifiers

PMID42797696
PMCPMC13611030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.